A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
A phase 2 trial of Inavolisib, Enzalutamide, Abiraterone acetate in prostate cancer, run by Hoffmann-La Roche, now recruiting.
Overview
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer is a phase 2 interventional study registered as NCT07287150 by Hoffmann-La Roche, with 100 participants planned, started 2026-03-11 and due to reach its primary completion in 2028-03-31. Interventions recorded: Inavolisib, Enzalutamide, Abiraterone, Docetaxel. Conditions listed: Metastatic Castration-Resistant Prostate Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialThe Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Shares Enzalutamide, Abiraterone acetate, Docetaxel, Prostate cancer.
- TrialAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Canc
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialStudy of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
Shares Enzalutamide, Abiraterone acetate, Docetaxel, Prostate cancer.
- TrialStudy of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
Shares Enzalutamide, Prostate cancer.
- TrialA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialAbiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialA Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialA Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.